Great to see our DEP program for AZD0466 featured in @AstraZeneca’s haematology update at #ASH2019. The FDA has approved an IND for the first in human trial for AZD0466 and phase 1 is expected to commence by the end of CY2019. Read more: https://astrazeneca.com/content/dam/az/Investor_Relations/events/AZN%20Investor%20science%20conference%20call%20ASH%202019%20Presentation.pdf… #SPL
Who's topping up, page-85
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
-0.001(1.08%) |
Mkt cap ! $38.39M | |||
| Open | High | Low | Value | Volume |
| 9.2¢ | 9.3¢ | 9.1¢ | $210.6K | 2.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 467139 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 152000 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |